Endosense (Switzerland) a commercial-stage medical device company focused on catheter ablation for the treatment of cardiac arrhythmias, closed a $36M Series B financing. Participants include Edmond de Rothschild Investment Partners, Neomed, Gimv, VI Partners, Sectoral Asset Management, Ysios Capital and Initiative Capital Romandie.

Catheter Connections ( Park City, UT) an early-stage focused on accessory products for the prevention of infection in the vascular catheter access device market, closed a $1.3M Series A financing. Participants include vSpring Capital and Kickstart Seed Fund.

iScience Interventional (Menlo Park, CA) a commercial-stage microcatheter device for the treatment of ocular diseases open-angle glaucoma and clinical-stage development focused on wet-AMD, closed a $20.5M Series F financing. Participants include Affinity Capital Management, Johnson & Johnson Development Corp., L Capital Partners, Clarian Health Ventures, Prism VentureWorks, Three Arch Ventures, DeNovo Ventures and Asset Management [...]

Ardian (Palo Alto, CA) a clinical-stage medical device company focused on catheter-based treatment for hypertension, chronic kidney disease and heart failure, closed a $47M Series C financing. Participants include Medtronic, Emergent Medical Partners, Advanced Technology Ventures, Morgenthaler Ventures and Split Rock Partners.

Concentric Medical (Mountain View, CA) a commercial-stage medical device company commercializing products for the restoration of blood flow in patients who are experiencing an ischemic stroke, closed a $15M Series D financing. Participants include New Enterprise Associates.

Flexicath (Israel) an early-stage developer of intravenous catheterization devices closed a $0.6M Series B financing. Participants include the Zitelman Group.

VasoNova (Sunnyvale, CA) developer of a self-guided peripherally inserted central catheters, closed a $10M Series B financing. Participants include Arboretum Ventures, Aphelion Capital, Coronis Medical Ventures and Research Corporation Technologies, Coronis Medical Ventures and Life Science Angels.

CoAxia (Maple Grive, MN) development-stage medical device company focused on a catheter-based therapy for cerebral ischemia, closed a $11.5M Series C financing. Participants include Canaan Partners, Prism Venture Partners, Baird Venture Partners, Affinity Capital Management, Johnson and Johnson Development Corporation and SVB Capital Partners.

Ekos Corp. (Bothell, WA) developer of drug delivery catheters leveraging ultrasound technology for peripheral arterial occlusions and administration of contrast media, closed a $5M Series C financing. Participants include ARCH Venture Partners, Bessemer Venture Partners, Merrill Lynch, Mitsui & Co., Spray Venture Partners, MedVenture Associates, Protostar, Technology Partners and Morgan Stanley Venture Partners.